Well, thats the investor point of view, when you buy spec share you mostly know it could go either way, the way people claiming chemotherapy is better than this than that is based on what? Do you have facts n figures, if you have known chemo is is better than any other why don’t you publish your findings in the peer review journals and be professor yourself, Here all OSL trying to do is add any possible treatment options available in combination with chemo or other radiation therapy so that those terminally ill patient could benefit in one way the other and live bit longer.. What’s wrong someone or some company trying to engage in helping to those who have been victim of this monster disease.. any person or company trying to find out any solution is better than nothing.. if you invested before and lost and burnt then its your fault not OSL’s, remember it is SPEC stock
OSL Price at posting:
11.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)